XML 94 R83.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' EQUITY (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance     $ 7,262  
Net earnings $ 273 $ 96 689 $ 408
Other comprehensive income (loss) (262) (73) (527) (95)
Other comprehensive income (loss) 6 $ 38 178 $ 379
Ending balance $ 7,037   $ 7,037  
Dividends declared (in dollar per share) $ 0.17 $ 0.17 $ 0.51 $ 0.51
Issued common stock        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance $ 3 $ 3 $ 3 $ 3
Ending balance 3 3 3 3
Capital in excess of par value        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance 2,633 2,602 2,637 2,614
Net issuance for executive stock plan 6 6 6 7
Net issuance of restricted stock 11 9 6 (4)
Purchase/sale of noncontrolling interest     1  
Ending balance 2,650 2,617 2,650 2,617
Treasury stock        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (1,936) (1,810) (1,812) (1,834)
Net issuance for executive stock plan (1)   4 3
Net issuance of restricted stock (2)   9 21
Purchase of treasury stock (100)   (240)  
Ending balance (2,039) (1,810) (2,039) (1,810)
Retained earnings        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance 7,005 6,527 6,671 6,296
Dividends declared (39) (41) (121) (122)
Net earnings 273 96 689 408
Ending balance 7,239 6,582 7,239 6,582
Accumulated other comprehensive income (loss)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (816) (673) (551) (651)
Other comprehensive income (loss) (262) (73) (527) (95)
Ending balance (1,078) (746) (1,078) (746)
Noncontrolling interests        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance 282 373 314 296
Dividends declared (15) (14) (64) (51)
Purchase of treasury stock 0   0  
Purchase/sale of noncontrolling interest     (4) (33)
Acquisition of AKASOL       96
Net earnings 19 21 58 77
Other comprehensive income (loss) (24) (6) (42) (11)
Ending balance $ 262 $ 374 $ 262 $ 374